Lataa...
Deciphering the late steps of rifamycin biosynthesis
Rifamycin-derived drugs, including rifampin, rifabutin, rifapentine, and rifaximin, have long been used as first-line therapies for the treatment of tuberculosis and other deadly infections. However, the late steps leading to the biosynthesis of the industrially important rifamycin SV and B remain l...
Tallennettuna:
| Julkaisussa: | Nat Commun |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6002545/ https://ncbi.nlm.nih.gov/pubmed/29904078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-04772-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|